FDA rejects use of MDMA for PTSD

The U.S. Food and Drug Administration (FDA) rejected on Sunday a request by a pharmaceutical company to approve MDMA (commonly known as Ecstasy) as a treatment for post-traumatic stress disorder (PTSD). The decision follows recommendations by the…